MYCIFRADIN vs TOBI PODHALER

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MYCIFRADIN and TOBI PODHALER are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYCIFRADIN	TOBI PODHALER
Rating	New	70/100
Pharmacy pays	~$25.36 /30	$1.08 /mL
Type	RX	RX
Active ingredient	NEOMYCIN SULFATE	TOBRAMYCIN
Manufacturer	Pharmacia and Upjohn	Viatris
Dosage forms	Tablet, Solution	Capsule
Drug class	Aminoglycoside Antibacterial	Aminoglycoside Antibacterial
Boxed warning	None	None
Treats	Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases	Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

mycifradin tobi podhaler

Rating

New

70/100

Pharmacy pays

~$25.36 /30

$1.08 /mL

Type

Active ingredient

NEOMYCIN SULFATE

TOBRAMYCIN

Manufacturer

Pharmacia and Upjohn

Viatris

Dosage forms

Tablet, Solution

Capsule

Drug class

Aminoglycoside Antibacterial

Boxed warning

None

Treats

Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases

Infectious Bone Diseases, Central Nervous System Infections, Pseudomonas Infections

Frequently asked questions

What is the difference between Mycifradin and Tobi Podhaler?

Mycifradin contains Neomycin Sulfate, while Tobi Podhaler contains Tobramycin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.